Lannett New York Listing Under Threat As FDA Says No On Advair

Flurry Of Announcements Also Sees Lannett Agree Sale Of Carmel Site

 
• By Dean Rudge
  
Clock disintegrates, time running out concept
Lannett has 45 days to submit a business plan to the NYSE • Source: Piotr Adamowicz / Alamy Stock Photo

More from Business

More from Generics Bulletin